Literature DB >> 1829928

Phase II study of navelbine in advanced renal cell carcinoma.

L Canobbio, F Boccardo, D Guarneri, C Calabria, A Decensi, A Curotto, G Martorana, L Giuliani.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1829928     DOI： 10.1016/0277-5379(91)90195-j

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN： 0959-8049            Impact factor:   9.162


× No keyword cloud information.
  2 in total

Review 1.  Vinorelbine. A review of its pharmacological properties and clinical use in cancer chemotherapy.

Authors:  K L Goa; D Faulds
Journal:  Drugs Aging       Date:  1994-09       Impact factor: 3.923

2.  Phase I trial of vinorelbine and diphenylhydantoin in patients with refractory carcinoma.

Authors:  Thomas E Hutson; Ram Ganapathi; Paul Elson; Tarek Mekhail; Thomas Olencki; G Thomas Budd; Ronald M Bukowski
Journal:  Invest New Drugs       Date:  2004-08       Impact factor: 3.850
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.